Sign Up Account Profile Log Out

Newsletters Morning Report 12:30 Report Evening Report Business Defense Health Care Technology Newsletter Energy & Environment Whole Hog Politics The Gavel The Movement

Technology Newsletter

NEWS Senate House Administration Courts Future America Media Campaign News Education In The Know Latino LGBTQ DC News Race & Politics State Watch Print Edition People in the News

POLICY Defense Health Care Energy & Environment Technology Transportation International Cybersecurity National Security Space Sustainability

BUSINESS Budget Taxes Personal Finance Lobbying

OPINION Columnists Congress Blog All Contributors Opinions – Campaign Opinions – Civil Rights Opinions – Criminal Justice Opinions – Cybersecurity Opinions – Education Opinions – Energy and Environment Opinions – Finance Opinions – Healthcare Opinions – Immigration Opinions – International Opinions – Judiciary Opinions – National Security Opinions – Technology Opinions – White House Submit Opinion Content

All Contributors Opinions – Campaign Opinions – Civil Rights Opinions – Criminal Justice Opinions – Cybersecurity Opinions – Education Opinions – Energy and Environment Opinions – Finance Opinions – Healthcare Opinions – Immigration Opinions – International Opinions – Judiciary Opinions – National Security Opinions – Technology Opinions – White House

Opinions – Civil Rights

Opinions – Criminal Justice

Opinions – Cybersecurity

Opinions – Energy and Environment

Opinions – Healthcare

Opinions – Immigration

Opinions – International

Opinions – National Security

Opinions – Technology

Opinions – White House

Submit Opinion Content

EVENTS Upcoming Events About

Sign Up Account Profile Log Out

Trump State of the Union

Trump approval rating

Content from Google Cloud

Live updates: Trump to tout economy at State of the Union; Top House Democrat to boycott Administration | 7 minutes ago

Supreme Court Strikes Down Tariffs: Will Your Next Car Cost Less? Domestic Taxes | 9 minutes ago

Trump heads to State of the Union with world on Iran watch Defense & National Security Newsletter | 18 minutes ago

Internal GOP disagreements paralyze 2026 legislative agenda Senate | 32 minutes ago

Epstein survivors join Democrats to press for accountability hours before State of the Union House | 37 minutes ago

Senate Democrats emerge from secret Iran briefing warning of ‘serious’ moment Senate | 44 minutes ago

Majority of Americans say US standing on world stage has deteriorated under Trump: Poll Administration | 48 minutes ago

Senate Democrats block DHS funding bill as impasse deepens Senate | 50 minutes ago

Novo Nordisk plans to slash GLP-1 prices 

Novo Nordisk plans to slash GLP-1 prices 

The list prices of GLP-1 medications like Wegovy and Ozempic are set to fall by up to 50 percent next year following an announcement by pharmaceutical giant Novo Nordisk. 

© Joel Saget, Agence France-Presse via Getty Images

Starting Jan. 1, the list price for Wegovy, Ozempic and Rybelsus, Novo’s semaglutide products, will be $675 across the board in the U.S. 

This reduction represents a 50 percent cut for oral and injectable Wegovy, with current list prices of $1,349.02. It’s a 34 percent cut for Ozempic and Ryeblsus, which are both now priced at $1,027.51. 

“Lowering the list price of Wegovy® and Ozempic® is the best approach to address the unprecedented opportunity to help more than 100 million people living with obesity and over 35 million people with type 2 diabetes in the United States,” Jamey Millar, executive vice president of Novo Nordisk’s U.S. operation, said in a statement. 

Due to high demand and interest, Novo has sought avenues to make its blockbuster line of semglutide products available at lower prices, launching direct-to-consumer portals and collaborations with telemedicine platforms to offer the drug without the autoinjector. 

Federal government pressures to lower prices have also come into play. 

The Centers for Medicare and Medicaid Services (CMS) selected semaglutide for Medicare negotiations last year. In November, CMS unveiled it had negotiated a 71 percent discount on a 30-day supply of semaglutide for Medicare, going from $959 to $274. These prices are scheduled to go into effect at the start of 2027. 

The Trump administration additionally pushed several companies, including Novo, to enter into “most favored nation” (MFN) drug pricing agreements last year, with manufacturers agreeing to sell their GLP-1 injectables for a monthly starting price starting of $245 for people on Medicare and Medicaid. 

When TrumpRx was launched earlier this month, Ozempic and Wegovy were among the first few dozen drugs offered on the platform, offering coupons hovering around 80 percent off the list price. 

A spokesperson for Novo Nordisk told The Hill that this slash in costs is unrelated to the company’s MFN agreement with the administration.

Welcome to The Hill’s Health Care newsletter, I’m Joseph Choi — every week I follow the latest moves on how Washington impacts your health.

Did someone forward you this newsletter? Subscribe here.

How policy will be impacting the health care sector this week and beyond:

Tennessee lawmakers float abortion amendment that would charge mothers with homicide

Two Republican lawmakers in Tennessee are floating an amendment to an abortion bill that would bring homicide charges against expecting mothers who choose to terminate their pregnancies. The GOP sponsors, state Rep. Jody Barrett (Dickson) and state Sen. Mark Pody (Lebanon), have not formally filed the amendment to House Bill 570/Senate Bill 738, according to Nashville’s NBC affiliate WSMV4. Text of the amendment provided …

Parents are underestimating their teens’ use of AI chatbots: Survey

There’s a wide gap between parents’ estimates of their teenagers’ AI chatbot activities and actual usage, according to new polling data.  A majority of teens in the U.S. — 64 percent — indicated they use AI chatbots in a Pew Research Center survey. About 3 in 10 said they use these services daily.  Parents of these polled teenagers underestimated such usage in the survey, with only 51 percent of parents saying that their …

Jillian Michaels on Trump, RFK Jr. defense of pesticide: ‘Devastating’

Health and wellness expert Jillian Michaels on Monday rebuked President Trump’s executive order approving the use of a controversial pesticide, describing the move as “devastating.”

Branch out with a different read:

Microplastics found in higher levels in prostate tumor tissue: Research

A new study released Tuesday found microplastics deep inside samples from 9 out of 10 patients with prostate cancer, with more microplastic levels inside tumors than in regular healthy tissue nearby. Researchers from the American Society of Clinical Oncology found that nylon-6 and polystyrene were the most commonly found microplastics found above certain detection limits, with polyethylene and polyethylene copolymers typically …

Local and state headlines on health care:

Louisiana ranks last in the U.S. for women and children health. See how other states compare. (NOLA.com) 

N.J. joined group to ‘uphold scientific integrity in public health.’ How does it work? (New Jersey Monitor) 

Washington Democrats drop push for business tax to cover Medicaid costs (Washington State Standard) 

Health news we’ve flagged from other outlets:

Hospitals fighting measles confront a challenge: Few doctors have seen it before (KFF Health News) 

In earnings call, Hims CEO addresses scrutiny of GLP-1 compounding (Stat) 

Price controls ‘inevitable’ in U.S. healthcare, economist says (MedPage Today) 

Opinions related to health submitted to The Hill:

Not so fast: Quick-moving AI leaves accountability behind in the dust

Why Medicaid has drifted from its mission — and how to fix It

You’re all caught up. See you tomorrow! 

Copyright 2026 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

More Health Care Newsletter News

Gorsuch takes aim at fellow Supreme Court justices in tariff decision

Hegseth says he’ll order random pizzas to throw off monitoring app

Platner holds double-digit lead on Mills, Collins in Maine Senate race: Poll

FCC got more complaints about Jimmy Kimmel’s suspension than about his ...

Pam Bondi thought grand jurors were stupid. They showed her a thing or two.

White House plays hardball with Democrats over DHS shutdown

Live updates: Trump to tout economy at State of the Union; Top House Democrat ...

Cornyn: Democrat winning Senate race in Texas would be ‘first crack in the ...

Democrats prepare to protest Trump State of the Union: What to know

Internal GOP disagreements paralyze 2026 legislative agenda

Here’s how Trump’s polling has changed since last year

Senate Democrats unveil proposal to discourage private equity ownership of homes

Senate Democrats emerge from secret Iran briefing warning of ...

House votes down aviation safety bill amid GOP, Pentagon concerns

Senate Democrats block DHS funding bill as impasse deepens

Supreme Court shields Postal Service from lawsuits over intentionally ...

‘Major’ wave of seaweed heading toward these beaches ahead of spring break

Trump puts Iran’s leader in double bind: Capitulation or risk of war

2024 Election Results

2024 Election Forecast

Regulation - Administration

Energy & Environment Video Clips

Health Care Video Clips

Technology Video Clips

Transportation Video Clips

International Video Clips

Cybersecurity Video Clips

National Security Video Clips

Contributors to The Hill

Submit Opinion Content

PRIVACY POLICY 09/30/2025

Advertise with Nexstar

Journalistic Integrity

THE HILL 400 N CAPITOL STREET NW, SUITE 650 WASHINGTON DC 20002

© 1998 - 2026 Nexstar Media Inc. | All Rights Reserved.

Provided by Nexstar Media Group, Inc.

Sign in to create a free account. No password needed.

By clicking on any of the sign up options below, you confirm that you have read and agree to our Terms of Use, which includes a jury trial waiver and class action waiver, and that you have read our Privacy Policy detailing our collection, use and sharing of your personal information.

By clicking on any of the sign up options below, you confirm that you have read and agree to our Terms of Use, which includes a jury trial waiver and class action waiver, and that you have read our Privacy Policy detailing our collection, use and sharing of your personal information.

The Hill is provided by Nexstar Media Group, Inc., and uses the My Nexstar sign-in, which works across our media network.

Learn more at nexstar.tv/privacy-policy.

The Hill is provided by Nexstar Media Group, Inc., and uses the My Nexstar sign-in, which works across our media network.

Nexstar Media Group, Inc. is a leading, diversified media company that produces and distributes engaging local and national news, sports, and entertainment content across its television and digital platforms. The My Nexstar sign-in works across the Nexstar network—including The CW, NewsNation, The Hill, and more. Learn more at nexstar.tv/privacy-policy.

Provided by Nexstar Media Group, Inc.

Check your email inbox

Provided by Nexstar Media Group, Inc.

Thanks for registering!

Provided by Nexstar Media Group, Inc.

Are you sure you want to log out?

Access, delete or correct your data

Access, delete or correct your data

Opt-out of targeted advertising

Opt-out of targeted advertising

Strictly necessary cookies

Strictly necessary cookies

Access, delete or correct your data

We allow you to access, delete, and/or correct your personal information. To submit a request to exercise these privacy rights, you may submit your request here.

If you would like to opt-out of the sale of your personal information and the sharing of your personal information to third parties for targeted advertising, please visit the “Opt-out of targeted advertising” tab – you do not need to submit any personally identifiable information to exercise this right.

If you would like to opt-out of non-essential cookies, please also select the “Opt-out of targeted advertising” tab.

Opt-out of targeted advertising

By moving the toggle to the left, you can opt-out of the sharing of your personal information with third parties for targeted advertising. This action will also opt you out of cookies that are not strictly necessary for the functioning of the Properties which may impact your experience and the services we are able to offer. However, you can opt-in again at any time by toggling to the right. If you have enabled privacy controls on your browser (such as a plugin), we will accept that as a valid request to opt-out. Please note that different devices and browsers use different identifiers and technologies, so you must opt-out separately from each one.

Performance Cookies Switch Label labelThese cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

Targeting Cookies Switch Label labelThese cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Unknown Cookies Switch Label labelUnknown cookies

Functional Cookies Switch Label labelThese cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.

These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.

Strictly necessary cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

© The Hill